Halozyme Therapeutics
HALO
#2342
Rank
A$11.43 B
Marketcap
A$96.41
Share price
0.36%
Change (1 day)
16.03%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2025 (TTM): A$0.72 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are A$1.39 Billion. a decrease over its 2024 earnings that were of A$0.77 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2025

Annual earnings

Year Earnings Change
2025 A$0.65 B-16.2%
2024 A$0.77 B59.94%
2023 A$0.48 B39.94%
2022 A$0.34 B0.16%
2021 A$0.34 B92.2%
2020 A$0.18 B-278.96%
2019 -A$0.11 Billion-9.45%
2018 -A$0.12 Billion-229.51%
2017 A$86.1 M-160.48%
2016 -A$0.15 Billion216.03%
2015 -A$45.05 Million-52.86%
2014 -A$95.57 Million-18.09%
2013 -A$0.12 Billion55.88%
2012 -A$74.85 Million169.94%
2011 -A$27.73 Million-63.44%
2010 -A$75.84 Million-7.19%
2009 -A$81.71 Million15.91%
2008 -A$70.49 Million83.89%
2007 -A$38.34 Million78.1%
2006 -A$21.53 Million16%
2005 -A$18.56 Million45.24%
2004 -A$12.78 Million682.42%
2003 -A$1.64 Million1659.12%
2002 -A$0.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.30 B 5,464.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$14.80 B 2,168.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$43.50 B 6,566.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.70 B 1,540.37%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-A$0.71 Billion-208.81%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
A$1.96 M-99.70%๐Ÿ‡บ๐Ÿ‡ธ USA